Other Briefings
Free Trade Warehousing Zones in India
Free Trade Warehousing Zones are expected to serve as a cost-efficient component within logistic and global supply chains, catering to the needs of both India and the international market.
Compliance Advisory: How Indian Firms Can Qualify for RCEP Benefits in Vietnam
Indian companies can access RCEP’s tariff advantages by setting up operations in Vietnam, but success depends on strict compliance with Rules of Origin, certification, and supply chain structuring.
China Bans Third-Party Export Documents: Advisory for Indian Importers
From October 1, 2025, China enforces STA Announcement 17, banning third-party export documents. Indian importers must adapt sourcing strategies, verify suppliers, and ensure full compliance.
GST Reforms in India: How Foreign Companies Can Prepare
India’s GST reforms effective September 22, 2025, simplify tax rates, cut costs in key sectors, improve input tax credit flows, and boost ROI. Explore key takeaways for foreign investors, from demand growth and compliance clarity to sector-specific opportunities in healthcare, infrastructure, renewables, and consumer goods.
India to Remove GST Compensation Cess from Sept. 22, 2025: Details Here
On September 22, 2025, India will phase out the GST compensation cess, a levy introduced in 2017 to safeguard state revenues during the transition to GST. This key reform carries wide-ranging implications for businesses, consumers, and investors.
India Proposes 100% FDI in Insurance: Market Entry Considerations
India is poised to permit 100 percent FDI in its insurance sector through the proposed Indian Insurance Companies (Foreign Investment) Amendment Rules, 2025. Learn how this policy shift could unlock full ownership opportunities for global insurers.
India’s GST Overhaul: What Goods Become Cheaper and What Gets Costlier
India’s GST Council has overhauled the indirect tax system, cutting rates on essentials, healthcare, agriculture, and consumer goods while simplifying slabs into 5%, 18%, and a new 40% de-merit rate. We explore how the new GST structure impacts consumers and businesses.
Registering a Pharmaceutical Company in India: How to Obtain CDSCO & Drug License Approvals
This guide covers matters related to incorporation, regulatory bodies and government approvals, documentation, and renewals—offering investors in the pharmaceuticals industry a clear roadmap to enter the Indian market.
